Респираторная медицина. Руководство (в 2-х томах) - Чучалин А. Г.

24.Selman M, Cisneros-Lira J, Gaxiola M et al: Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs// Chest (2003) 123: 1633-1641.

25.Beeh KM, Beier J, Kornmann O, Buhl R Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1 and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.// Respir Med 97(2003): 634-639

26.Higashimoto Y, Yamagata Y Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients// Eur Respir J. 2005 May;25(5):885-90.

27. Vignola A, Riccobono M, Mirabella A. Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis //Am. J. Respir. Crit. Care Med., Volume 158, Number 6, December 1998, 1945-1950

28.Joyce E. Rundhaug Matrix metalloproteinases and angiogenesis// J. Cell. Mol. Med. Vol 9, No 2, 2005 pp. 267-285

29.Russell RE, Thorley A, Culpitt SV et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases// Am J Physiol Lung Cell Mol Physiol 2002;283:867 - 873.

30. Takeyabu K, Betsuyaku T, Nishimura M et al. Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema// Eur Respir J 1998;12:1033 - 1039

31.Wang Z, Zheng T, Zhu Z et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung// J Exp Med 2000;192:1587 - 1600

32.Henson P.M., Vandivier RW, Douglas S.I. Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?// The Proceedings of the American Thoracic Society (2006)3:713-717

33.Fang KC, Wolters PJ, Steinhoff M, et al. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.// J Immunol 1999;162:5528 - 35

34.Kucich U, Rosenbloom JC, Abrams WR, et al.: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta and p38.// Am J Respir Cell Mol Biol 2002;26:183 - 8

35.Bonniaud P, Kolb M, Galt T et al: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.//J Immunol 2004;173:2099 - 2108

36.Pons R, Sauleda J., Noguera A. et al: Decreased macrophage release of TGF-бета and TIMP-1 in chronic obstructive pulmonary disease // Eur. Respir. J., July 1, 2005; 26(1): 60 - 66

37.Aoshiba K, Nagai A. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.//Clin Rev Allergy Immunol 2004;27:35 - 43

38.Hodge S, Hodge G, Scicchitano R et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.// Immunol Cell Biol. 2003;81:289 - 296.

39.Vandivier RW, Fadok VA, Hoffmann PR et al: Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.// J Clin Invest. 2002;109:661 - 670

40.Vlanovich G, Russel ML, Mercer RR, Crapo JD . Cellular and Connective Tissue Changes in Alveolar Septal Walls in Emphysema //Am. J. Respir. Crit. Care Med., Vol 160, Number 6, 1999, 2086-2092

41.Massaro GD, Radaeva S, Clerch LB, Massaro D. Lung alveoli: endogenous programmed destruction and regeneration// Am J Physiol Lung Cell Mol Physiol 2002.283: 305-309

42.Barnes P. J., Stockley R. A. COPD: current therapeutic interventions and future approaches //Eur Respir J 2005; 25:1084-1106

43.Stein J, Fenigstein H. Pathological anatomy of hunger disease.// In: Winick M, editor. Hunger disease: studies by the Jewish physicians in the Warsaw Ghetto: current concepts in nutrition. New York: John Wiley & Sons; 1979. p. 207 - 211

44.Kerr JS, Riley DJ, Lanza-Jacoby S, et al. Nutritional emphysema in the rat // Am Rev Respir Dis 1985;131:644 - 650

45.Coxson H., Ida H. Chan T., Mayo J Early Emphysema in Patients with Anorexia Nervosa// Am J Respir and Crit Care Med 2004;Vol 170. pp. 748-752

46.Patel BD, Loo WJ, Tasker AD et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax. 2006 Jul;61(7):568-671

47.Uppaluri R, Mitsa T, Sonka M et al. Quantification of pulmonary emphysema from lung computed tomography images.// Am J Respir Crit Care Med 1997;156:248 - 254

48.Sanders C, Nath PH, Bailey W. Detection of emphysema with computed tomography: correlation with pulmonary function tests and chest radiography.// Invest Radiol 1988;23:262 - 266

49.Власов П.В. Лучевая диагностика заболеваний органов грудной полости// «Видар», 2006, стр.65-77

50.Morgan MDL: Detection and quantification of pulmonary emphysema by computed tomography: a window of opportunity// Thorax 1992;47:1001 - 1004

51.Gevenois PA, de Maertelaer V, De Vuyst P et al.: Comparison of computed density and macroscopic morphometry in pulmonary emphysema.// Am J Respir Crit Care Med 1995;152:653 - 657

52.Parr D. G., Dawkins P. A., Stockley R. A. Computed tomography: a new gold standard for the clinical assessment of emphysema//Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 954 - 954

53.Watz H, Breithecker A, Rau W. Micro-CT of the Human Lung: Imaging of Alveoli and Virtual Endoscopy of an Alveolar Duct in a Normal Lung and in a Lung with Centrilobular Emphysema - Initial Observations// Radiology 2005;236:1053-1058

54.Chapman K.R., Stockley R.A., Dawkins C. et al . Augmentation therapy for альфа1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies.// Eur. Respir. J. 2005; 26 (49): 288

55.Wencker M., Fuhrmann B., Banik N. et al. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.// Chest. 2001; 119:737-744.

56.Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.// Chest 2000; 118:1480 - 1485.

57.Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.// Am J Med 2000;109:207 - 212.

58.Finnerty JP, Keeping I, Bullough I, Jones J: The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: randomized controlled trial// Chest 2001; 119: 1705-1710

59.Martinez F, Foster G, Curtis J. Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction// American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 1326-1334, (2006)

60.Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.// N Engl J Med 2004; 350:1005 - 1012

61.Kanner RE, Renzetti AD , Stanish WM et al. Predictors of survival in subjects with chronic airflow limitation// Am J Med 1983;74:249 - 255.

62.Nikoladze G.D. Functional results of surgery for bullous emphysema.// Chest 101: 119-122, 1992

63.Brantigan O, Mueller E. Surgical treatment of pulmonary emphysema.// Am Surg 1957. 23,789-804.

64.Cooper, JD, Trulock, EP, Triantafillou, AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.// J Thorac Cardiovasc Surg (1995) 109,106-116.

65.Meyers BF, Yusen RD, Guthrie TJ, et al: Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. //J Thorac Cardiovasc Surg 2004. 127:829-835

66.Tutic M, Lardinois D, Imfeld S.: Lung-Volume Reduction Surgery as an Alternative or Bridging Procedure to Lung Transplantation.// Ann Thorac Surg 2006; 82:208-213.

67.Wan IY, Toma TP, Geddes DM. Bronchoscopic Lung Volume Reduction for End-Stage Emphysema Report on the First 98 Patients// Chest. 2006;129:518-526